TradingView
RocketTickers
Sep 25, 2019 4:37 PM
AzurRx BioPharma Announces Positive Results from Phase 2 Trial w
Long
NASDAQ:AZRX
1D
Description
⋅
Sep 25, 2019 4:37 PM
AZRX: AzurRx BioPharma, Inc.
2019-09-25 07:30:00
AzurRx BioPharma Announces Positive Results from Phase 2 Trial with MS1819 in Cystic Fibrosis Patients
Beyond Technical Analysis
More